We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Warns of Unforeseen Consequences of Listing Prices in Drug Ads
PhRMA Warns of Unforeseen Consequences of Listing Prices in Drug Ads
The administration’s proposal to require disclosure of list prices for drugs could hurt Medicare and Medicaid beneficiaries, PhRMA claimed in a 30-page comment on CMS’ proposed rule.